Navigation Links
Analysis of ASCO's QOPI® data finds significant improvement in performance on metrics for quality oncology care
Date:3/11/2013

as recommended. Adjuvant therapy is proven to extend survival and often offer cures for many patients with these cancers.
  • Improved uptake of new clinical practices: Mean scores of measures related to new clinical practices (based on new guidelines or clinical evidence) improved from 5 to 69 percent overall over four years. These new clinical practices include genetic testing for tumor molecular markers that predict response to treatment in patients with metastatic colorectal cancer (KRAS gene alterations before administering anti-EGFR therapy), adequate lymph node examination after surgery in colorectal cancer, testing for, and use of the anti-nausea drug aprepitant when certain chemotherapy regimens are administered.
  • There are opportunities for improvement for certain measures: Measures that assess smoking cessation and fertility preservation counseling (for patients undergoing treatment that could render them infertile) did not improve over time. Performance on these measures ranged from a high of 34 percent for smoking cessation counseling to a low of 6 percent for discussion of fertility preservation.

    "These findings demonstrate that oncologists are consistently performing at high levels in many core areas of care and are quickly incorporating new standard tests and treatments into everyday practice," said lead author Michael N. Neuss, MD, chief medical officer at the Vanderbilt-Ingram Cancer Center and Chair of the QOPI Steering Group. "These data also show that participation in quality measurement programs, like QOPI, is correlated with substantial improvement in adherence to clinical practice standards."

    QOPI holds its two semi-annual collection rounds in the spring and fall. The current analysis included 156 practices that participated in at least two collection rounds and reported data from 30 or more patient charts per round. Performance scores (rates of adherence to quality measures) were calculated for seven ca
    '/>"/>


  • Contact: Aaron Tallent
    Aaron.Tallent@asco.org
    571-483-1371
    American Society of Clinical Oncology
    Source:Eurekalert

    Page: 1 2 3

    Related medicine news :

    1. Network analysis of the brain may explain features of autism
    2. MinistryKeys: Using DISC Behavioral Analysis to Help Religious Organizations Achieve Goals for 2013
    3. BRICS Mobility Aids and Transportation Equipment Market Analysis & 2018 Forecasts in New Research Report at RnRMarketResearch.com
    4. Rice University analysis links ozone levels, cardiac arrest
    5. Deep genomic analysis identifies a micro RNA opponent for ovarian cancer
    6. CT texture analysis of tumors may be a valuable biomarker in localized esophageal cancer
    7. Re-Analysis Refutes Diet Guidelines Favoring Vegetable Fats
    8. Economic analysis finds penicillin, not "the pill," may have launched the sexual revolution
    9. Canada In Vitro Diagnostics Market Analysis and Forecasts to 2017 in New Research Report at RnRMarketResearch.com
    10. U.S. Medical Waste Market Analysis: Treatment, Containment, Management and Disposal Products Reviewed in New Research Report at ReportsnReports.com
    11. New analysis examines stakes for Medicaid in upcoming fiscal cliff negotiations on Capitol Hill
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/25/2014)... 2014 The microscopy market is ... to reach $5,756.0 million by 2019. Optical microscopy ... The electron microscopes product segment is expected to ... , Rising focus on nanotechnology, technological advancements, and ... microscopy market. , Get Full Copy of Report ...
    (Date:12/25/2014)... 2014 The report “Nintedanib (Colorectal ... focuses on the current treatment landscape, unmet needs, ... cancer market. Stivarga is a drug which is ... cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), an ... refractory CRC in the US, Europe, and Japan. ...
    (Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
    (Date:12/25/2014)... The short film “Color of Honor” by young ... a true 9/11 hero, Welles Remy Crowther. It has been ... hours of Nuremberg International Short Film Festival and the 8th ... screenwriter and director Luciana Lagana plays the mother of ... husband, Gregory Graham - Graham plays a heroic ...
    (Date:12/25/2014)... (PRWEB) December 25, 2014 Helen Harris’ ... in Woodland Hills, California after an 8 year battle ... on Christmas Eve evening in her home in Woodland ... metastatic breast cancer. , As the ... forty years, she pioneered and championed many of today's ...
    Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4
    ... WASHINGTON, Jan. 11 The Executive Council of the International ... to oppose any health care reform legislation that is funded ... , "For decades, IAM members exchanged substantial wage increases for ... "Now, in a bizarre turn of events, their insurance premiums ...
    ... , DUBLIN, Calif., Jan. 11 ... today announced it received an additional over-the-counter (OTC) clearance ... for its flagship product, TRIA Laser Hair Removal System ... hair reduction, making it the first and only at-home ...
    ... 2010 - A new study by a researcher at ... moods impact the number of prescriptions, referrals and lab ... they spend talking with their patients. The findings of ... to Tests and Specialists: Associations with Physician Burnout and ...
    ... a more strongly evidence-based approach to medicine would help ... nations and improve quality, access, efficiency, equity and healthy ... International Journal of Public Policy this month. ... Public Health, at the University of North Florida, in ...
    ... safe practices only about half the time, study finds, ... made for kids are getting better at portraying safety ... they,re still missing the mark about half the time. ... been tracking injury-prevention practices in movies since 1995. The ...
    ... , CHICAGO, Jan. 11 ... Stimulus Program , making it safe and easy for physicians ... qualify for significant federal incentives. , (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ... a guarantee that the Allscripts EHR they select will meet ...
    Cached Medicine News:Health News:Machinists Union Leaders Vote to Oppose Health Benefits Tax 2Health News:FDA Grants Permanent Hair Reduction Labeling for TRIA Laser Hair Removal System 2Health News:Considering the evidence in health care 2Health News:Seat Belts, Bike Helmets Go Unused in Movies Aimed at Kids 2Health News:Seat Belts, Bike Helmets Go Unused in Movies Aimed at Kids 3Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 2Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 3Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 4Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 5Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 6
    (Date:12/24/2014)... CHENGDU, China, Dec. 24, 2014 /PRNewswire/  -- Tianyin ... a pharmaceutical company that specializes in the patented ... and active pharmaceutical ingredients (API) released unaudited preliminary ... year 2015. Fiscal Year 2015 Ended ... was $9.7 million compared with $14.7 million in ...
    (Date:12/24/2014)... Dec. 24, 2014 Soligenix, Inc. (OTCQB: ... company developing products that address unmet medical needs ... announced today that on December 24, 2014 it ... The Company raised approximately $2.3 million in ... use the net proceeds from the offering to ...
    (Date:12/24/2014)... , Dec. 24, 2014  Conkwest, Inc., the ... the proprietary Natural Killer (NK) cell-line platform, Neukoplast® ... Patrick Soon-Shiong , NantWorks founder, physician scientist ... agreement to purchase approximately $48 million of the ... the investment, he will be named Co-Chairman of ...
    Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5
    ... Subjects with ALS, RICHMOND, Calif., Sept. 3 ... it has opened a Phase,2 clinical trial (SB-509-801) to ... degenerative motor-neuron disease for which there,are limited treatment options ... injectable formulation of a plasmid,encoding a zinc finger DNA-binding ...
    ... , - This Analysis Showed That Multaq(R) (Dronedarone) ... Atrial Fibrillation or Atrial Flutter,Already Adequately Treated by Antithrombotic ... the data from the ATHENA study,were presented today at ... Cardiology congress 2008, in Munich, Germany. Previous results,from the ...
    Cached Medicine Technology:Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5
    Tilt Adapter for the 8000 Sliding Microtome to allow for orientation of the specimen....
    ... Microtome has a look that is revolutionary, a ... functions and capabilities that will please the most ... experience and knowledge but still breaking new ground ... will be the answer to many of your ...
    Clock oil, 6 grams net...
    Knife sharpening back for Standard Knife, C Profile...
    Medicine Products: